Ocular implant made by a double extrusion process
First Claim
Patent Images
1. A bioerodible implant for treating a medical condition of the eye comprising a continuous, double extruded rod including an active agent homogeneously dispersed within a biodegradable polymer matrix, wherein the biodegradable polymer matrix comprises a mixture of PLGA having hydrophilic end groups and PLGA having hydrophobic end groups, and wherein the bioerodible implant is sized for implantation in an ocular region.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.
-
Citations
9 Claims
- 1. A bioerodible implant for treating a medical condition of the eye comprising a continuous, double extruded rod including an active agent homogeneously dispersed within a biodegradable polymer matrix, wherein the biodegradable polymer matrix comprises a mixture of PLGA having hydrophilic end groups and PLGA having hydrophobic end groups, and wherein the bioerodible implant is sized for implantation in an ocular region.
-
9. A bioerodible implant for treating a medical condition of the eye comprising a continuous, double extruded rod including dexamethasone homogeneously dispersed within a PLGA polymer matrix, wherein the bioerodible implant comprises approximately 60% by weight dexamethasone, approximately 30% by weight PLGA polymers having end groups consisting of —
- COOH, and approximately 10% by weight PLGA polymers having end groups consisting of the formula —
COOR wherein R=alkyl, and wherein the bioerodible implant is sized for implantation in an ocular region.
- COOH, and approximately 10% by weight PLGA polymers having end groups consisting of the formula —
Specification